In recent years, medications such as semaglutide — widely known under brand names like Ozempic and Wegovy — have transformed the treatment of obesity and metabolic disease. But these drugs are now appearing in an unexpected place: fertility conversations.
Some patients taking GLP-1 medications report becoming pregnant after years of infertility. Others are actively asking whether semaglutide and fertility may be connected. Can medications like Ozempic actually influence reproductive health?
Understanding how semaglutide and fertility interact requires looking beyond the drug itself and examining the metabolic changes these medications create in the body.
Recent reports of unexpected pregnancies while using GLP-1 medications are often referred to as “Ozempic babies.” In a previous article, we explored why these pregnancies occur and what they may mean for patients considering treatment.
Why GLP-1 Medications Are Part of Fertility Conversations
GLP-1 receptor agonists such as semaglutide were originally developed to treat type 2 diabetes. Today they are also widely prescribed for weight loss because they regulate appetite, insulin levels, and blood sugar.
These metabolic effects are closely tied to reproductive health.
Excess weight and insulin resistance can disrupt ovulation, alter hormone levels, and contribute to conditions such as polycystic ovary syndrome (PCOS). Even modest weight loss can help restore regular menstrual cycles and ovulation in some women.
Because semaglutide often leads to significant weight loss and improved metabolic function, fertility specialists are increasingly observing changes in reproductive patterns among patients using these medications.
This has led many people to ask an important question: does semaglutide affect female fertility?
Does Semaglutide Affect Female Fertility?
At present, there is no evidence that semaglutide directly increases fertility. The medication itself is not a fertility treatment.
However, semaglutide and fertility may be connected indirectly through metabolic improvements.
Weight loss and improved insulin sensitivity can restore ovulation in women whose cycles were previously irregular. This is particularly common in women with PCOS, a condition in which hormonal imbalance can prevent regular ovulation.
When ovulation resumes, the chances of pregnancy naturally increase.
This is why some women unexpectedly become pregnant while taking medications like Ozempic.
Why Some Women Become Pregnant While Taking Ozempic
The phenomenon often described online as “Ozempic fertility” is usually the result of improved metabolic health rather than a direct drug effect.
Several factors may contribute:
Restored ovulation. Weight loss and improved hormone balance can allow ovulation to resume after months or years of irregular cycles.
Improved insulin sensitivity. Insulin resistance is closely linked to reproductive hormone disruption. Improving metabolic health may normalize reproductive signaling.
Hormonal regulation in PCOS. For women with PCOS, weight loss and metabolic improvements can significantly improve ovulatory function.
Together, these changes can increase the likelihood of pregnancy, sometimes unexpectedly.
This is why patients occasionally ask whether Ozempic makes you more fertile. The reality is more nuanced: the medication does not act as a fertility drug, but the metabolic changes it produces can make pregnancy more likely in some individuals.
Should You Stop Semaglutide Before Trying to Conceive?
One of the most common questions patients ask is whether semaglutide should be continued while trying to conceive.
Current medical guidance recommends stopping semaglutide and other GLP-1 medications before pregnancy. These drugs have not been adequately studied in pregnant women, and animal studies have raised concerns about fetal development.
For this reason, manufacturers recommend discontinuing semaglutide at least two months before attempting pregnancy.
Patients who are considering pregnancy should speak with a fertility specialist or physician about the safest way to transition off the medication while maintaining metabolic health.
What Fertility Specialists Want Patients to Know
Interest in semaglutide and fertility continues to grow as GLP-1 medications become more widely used.
For patients struggling with obesity, metabolic syndrome, or PCOS, improving metabolic health may support reproductive function. However, medications such as Ozempic are not fertility treatments and should not be used with the expectation of improving fertility directly.
Anyone taking GLP-1 medications who is planning pregnancy should discuss their treatment plan with a qualified physician. A fertility specialist can help determine when to stop medication and how to safely transition toward conception.
FAQs: Semaglutide and Fertility
Why New Hope?
New Hope Fertility Center is home to world-renowned fertility specialists. We offer personalized, compassionate care backed by decades of experience. Our team has helped thousands of men and women understand their fertility options and guide them on their unique fertility journey.
If you are looking for trusted, expert fertility care in New York City, contact New Hope Fertility today. Call us at (347) 970-8479 or schedule your initial consultation now.
Written by the New Hope Editorial Team
As experts in IVF and Assisted Reproductive Technologies, we are committed to educating and empowering people on their fertility journey with accurate information and compassionate care.